ArticleReumatologia2016

Rivaroxaban - a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases.

Ewa Haładyj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.